Dr. Peter Greenberg

Biography

Peter Greenberg is a Professor Emeritus in the Department of Medicine specializing in Hematology at Stanford University. He has a distinguished career focusing on myelodysplastic syndromes (MDS) and other clonal myeloid disorders. Greenberg served as the Director of the Stanford MDS Center, where he has been heavily involved in clinical practice and research aimed at improving treatment outcomes for patients with MDS. His research includes the coordination of clinical trials utilizing experimental drugs and he has been pivotal in developing the revised MDS classification system known as the IPSS-R. He is the chair of the National Comprehensive Cancer Network Practice Guidelines Panel for MDS and has contributed significantly to the advancement of prognostic systems including IPSS-Molecular. Greenberg's academic influences are also recognized through numerous awards, including lifetime achievement awards from both the MDS Foundation and the International Workshop on MDS. His professional affiliations include memberships in the American Society of Hematology and the Eastern Cooperative Oncology Group. Educationally, he holds an M.D. from George Washington University and has extensive training in hematology and oncology, as well as prior research focused on the biology of myeloid progenitor cells and gene expression in MDS patients.

Research Interests

Experience

Courses